Protecting people against vaccine preventable infectious diseases.

Dynavax’s pipeline is focused on harnessing our CpG 1018 adjuvant as an advanced vaccine adjuvant to discover, develop, and commercialize promising vaccines to prevent infectious diseases.

dynavax pipeline graphic

Partnership

Transforming the treatment of life-threatening diseases requires a science-driven approach, a dynamic team, and constant innovation. If you are of the same mindset and would like to collaborate with Dynavax, contact our business development department.

Contact

businessdev@dynavax.com